Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Space Flight | 5 | 2019 | 19 | 2.080 |
Why?
|
| Cartilage, Articular | 6 | 2019 | 68 | 1.980 |
Why?
|
| Whole-Body Irradiation | 4 | 2015 | 48 | 1.660 |
Why?
|
| Knee Joint | 3 | 2019 | 129 | 1.620 |
Why?
|
| Hindlimb Suspension | 4 | 2019 | 11 | 1.490 |
Why?
|
| Animals | 22 | 2019 | 7297 | 0.690 |
Why?
|
| Bone and Bones | 5 | 2014 | 87 | 0.660 |
Why?
|
| Hip Joint | 1 | 2019 | 57 | 0.650 |
Why?
|
| Dose-Response Relationship, Radiation | 5 | 2019 | 76 | 0.600 |
Why?
|
| Weight-Bearing | 2 | 2016 | 40 | 0.590 |
Why?
|
| Anus Neoplasms | 1 | 2016 | 9 | 0.590 |
Why?
|
| Femur Neck | 1 | 2016 | 19 | 0.590 |
Why?
|
| Pelvis | 1 | 2016 | 61 | 0.560 |
Why?
|
| Arthritis | 1 | 2016 | 37 | 0.560 |
Why?
|
| Sarcoma, Experimental | 1 | 2016 | 4 | 0.560 |
Why?
|
| Spasm | 1 | 2016 | 5 | 0.560 |
Why?
|
| Radiation, Ionizing | 2 | 2015 | 22 | 0.550 |
Why?
|
| Ribs | 1 | 2016 | 40 | 0.540 |
Why?
|
| Weightlessness | 1 | 2015 | 5 | 0.540 |
Why?
|
| Radiometry | 1 | 2015 | 39 | 0.530 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 56 | 0.530 |
Why?
|
| Joints | 1 | 2014 | 9 | 0.510 |
Why?
|
| Angiotensin I | 1 | 2016 | 262 | 0.470 |
Why?
|
| Muscle, Skeletal | 2 | 2016 | 494 | 0.450 |
Why?
|
| Radiosurgery | 1 | 2016 | 322 | 0.440 |
Why?
|
| Peptide Fragments | 1 | 2016 | 420 | 0.440 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 384 | 0.420 |
Why?
|
| Mice | 10 | 2019 | 2368 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 711 | 0.400 |
Why?
|
| Bone Density | 4 | 2018 | 182 | 0.390 |
Why?
|
| Etidronic Acid | 1 | 2009 | 3 | 0.360 |
Why?
|
| Bone Density Conservation Agents | 1 | 2009 | 20 | 0.360 |
Why?
|
| Osteogenesis | 2 | 2015 | 75 | 0.360 |
Why?
|
| Osteoporosis | 1 | 2009 | 51 | 0.340 |
Why?
|
| Osteoclasts | 1 | 2008 | 22 | 0.330 |
Why?
|
| Tibia | 4 | 2016 | 56 | 0.320 |
Why?
|
| X-Ray Microtomography | 3 | 2019 | 40 | 0.320 |
Why?
|
| Alligators and Crocodiles | 2 | 2005 | 3 | 0.310 |
Why?
|
| Locomotion | 2 | 2005 | 31 | 0.310 |
Why?
|
| Rats | 3 | 2016 | 1604 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2018 | 871 | 0.290 |
Why?
|
| Glycosaminoglycans | 3 | 2016 | 20 | 0.290 |
Why?
|
| Disease Models, Animal | 4 | 2019 | 980 | 0.280 |
Why?
|
| Cell Proliferation | 1 | 2008 | 573 | 0.280 |
Why?
|
| Male | 10 | 2019 | 17768 | 0.270 |
Why?
|
| Tail | 1 | 2004 | 6 | 0.240 |
Why?
|
| Femur | 3 | 2016 | 67 | 0.240 |
Why?
|
| Osteoarthritis | 2 | 2014 | 74 | 0.230 |
Why?
|
| Gait | 1 | 2004 | 115 | 0.230 |
Why?
|
| Chondrocytes | 2 | 2013 | 71 | 0.220 |
Why?
|
| Punctures | 2 | 2019 | 32 | 0.210 |
Why?
|
| Hindlimb | 2 | 2016 | 57 | 0.200 |
Why?
|
| Protons | 2 | 2012 | 23 | 0.190 |
Why?
|
| Adaptation, Ocular | 1 | 2019 | 1 | 0.180 |
Why?
|
| Blood-Retinal Barrier | 1 | 2019 | 1 | 0.180 |
Why?
|
| Swine | 3 | 2019 | 201 | 0.180 |
Why?
|
| Organ Size | 2 | 2018 | 196 | 0.180 |
Why?
|
| Tissue Transplantation | 1 | 2019 | 16 | 0.180 |
Why?
|
| Tissue Culture Techniques | 1 | 2019 | 40 | 0.180 |
Why?
|
| Menisci, Tibial | 1 | 2019 | 24 | 0.180 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2019 | 48 | 0.170 |
Why?
|
| Amnion | 1 | 2019 | 36 | 0.170 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 42 | 0.160 |
Why?
|
| Ascorbic Acid | 1 | 2018 | 21 | 0.160 |
Why?
|
| Female | 7 | 2019 | 18114 | 0.160 |
Why?
|
| Musculoskeletal Diseases | 1 | 2018 | 36 | 0.150 |
Why?
|
| Lumbar Vertebrae | 1 | 2018 | 97 | 0.150 |
Why?
|
| Antioxidants | 1 | 2018 | 114 | 0.150 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 519 | 0.150 |
Why?
|
| Macaca mulatta | 1 | 2018 | 322 | 0.150 |
Why?
|
| Body Weight | 2 | 2016 | 290 | 0.150 |
Why?
|
| Probability | 1 | 2016 | 150 | 0.140 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 104 | 0.140 |
Why?
|
| Rib Fractures | 1 | 2016 | 20 | 0.140 |
Why?
|
| Muscle Neoplasms | 1 | 2016 | 8 | 0.140 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 98 | 0.140 |
Why?
|
| International Agencies | 1 | 2015 | 6 | 0.140 |
Why?
|
| Radiobiology | 1 | 2015 | 4 | 0.140 |
Why?
|
| Mice, Inbred Strains | 1 | 2016 | 43 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 1218 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2017 | 149 | 0.140 |
Why?
|
| Congresses as Topic | 1 | 2015 | 37 | 0.140 |
Why?
|
| Radiation Injuries | 1 | 2016 | 67 | 0.140 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 89 | 0.140 |
Why?
|
| Fibrosis | 1 | 2016 | 102 | 0.140 |
Why?
|
| Weightlessness Simulation | 1 | 2015 | 1 | 0.130 |
Why?
|
| Oncostatin M | 1 | 2015 | 2 | 0.130 |
Why?
|
| Particle Accelerators | 1 | 2015 | 7 | 0.130 |
Why?
|
| Information Dissemination | 1 | 2015 | 41 | 0.130 |
Why?
|
| Reference Values | 1 | 2016 | 224 | 0.130 |
Why?
|
| Random Allocation | 1 | 2016 | 212 | 0.130 |
Why?
|
| Research | 1 | 2015 | 72 | 0.130 |
Why?
|
| Collagen | 1 | 2016 | 217 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2015 | 46 | 0.130 |
Why?
|
| Analysis of Variance | 1 | 2016 | 454 | 0.130 |
Why?
|
| Nanotechnology | 1 | 2014 | 15 | 0.130 |
Why?
|
| Environmental Exposure | 1 | 2015 | 86 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 441 | 0.130 |
Why?
|
| Logistic Models | 1 | 2016 | 725 | 0.120 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 531 | 0.120 |
Why?
|
| Lower Extremity | 1 | 2015 | 93 | 0.120 |
Why?
|
| Humans | 7 | 2019 | 29013 | 0.120 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 125 | 0.120 |
Why?
|
| Middle Aged | 3 | 2017 | 10805 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 747 | 0.120 |
Why?
|
| Time Factors | 1 | 2019 | 1997 | 0.120 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2013 | 4 | 0.120 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 10 | 0.120 |
Why?
|
| Fibronectins | 1 | 2013 | 34 | 0.120 |
Why?
|
| X-Rays | 2 | 2013 | 6 | 0.110 |
Why?
|
| Proteoglycans | 1 | 2012 | 29 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2012 | 80 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2013 | 666 | 0.110 |
Why?
|
| Adult | 2 | 2016 | 8391 | 0.110 |
Why?
|
| Cell Survival | 1 | 2012 | 272 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 3712 | 0.100 |
Why?
|
| DNA | 1 | 2012 | 204 | 0.100 |
Why?
|
| Cells, Cultured | 2 | 2013 | 799 | 0.100 |
Why?
|
| Aged | 3 | 2019 | 9462 | 0.090 |
Why?
|
| Cosmic Radiation | 1 | 2009 | 13 | 0.090 |
Why?
|
| Humerus | 1 | 2009 | 29 | 0.090 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2009 | 104 | 0.080 |
Why?
|
| Rabbits | 2 | 2019 | 185 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2019 | 855 | 0.070 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2004 | 20 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2004 | 32 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2019 | 670 | 0.060 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 45 | 0.060 |
Why?
|
| Models, Biological | 1 | 2005 | 372 | 0.060 |
Why?
|
| Cytokines | 1 | 2004 | 243 | 0.050 |
Why?
|
| Radiography | 2 | 2018 | 353 | 0.050 |
Why?
|
| United States | 2 | 2019 | 3604 | 0.050 |
Why?
|
| Crystallins | 1 | 2019 | 1 | 0.040 |
Why?
|
| Aquaporin 4 | 1 | 2019 | 1 | 0.040 |
Why?
|
| Elastic Modulus | 1 | 2019 | 24 | 0.040 |
Why?
|
| Pressure | 1 | 2019 | 54 | 0.040 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2019 | 37 | 0.040 |
Why?
|
| Intraocular Pressure | 1 | 2019 | 25 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2019 | 33 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2019 | 128 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 92 | 0.040 |
Why?
|
| Needles | 1 | 2018 | 28 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2019 | 179 | 0.040 |
Why?
|
| Medicare | 1 | 2019 | 185 | 0.040 |
Why?
|
| Complex Regional Pain Syndromes | 1 | 2018 | 19 | 0.040 |
Why?
|
| Apoptosis | 1 | 2019 | 337 | 0.040 |
Why?
|
| Stress, Mechanical | 2 | 2008 | 90 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2017 | 446 | 0.040 |
Why?
|
| Length of Stay | 1 | 2017 | 291 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2018 | 170 | 0.040 |
Why?
|
| Osteoprotegerin | 1 | 2015 | 1 | 0.030 |
Why?
|
| RANK Ligand | 1 | 2015 | 4 | 0.030 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2015 | 34 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 100 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2015 | 224 | 0.030 |
Why?
|
| Cell Line | 1 | 2015 | 449 | 0.030 |
Why?
|
| Hydroxyproline | 1 | 2013 | 3 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 50 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2015 | 436 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 3509 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2019 | 3107 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3099 | 0.020 |
Why?
|
| Radiation Dosage | 1 | 2009 | 72 | 0.020 |
Why?
|
| Synchrotrons | 1 | 2008 | 3 | 0.020 |
Why?
|
| Sunlight | 1 | 2008 | 17 | 0.020 |
Why?
|
| Ultraviolet Rays | 1 | 2008 | 46 | 0.020 |
Why?
|
| Electromyography | 1 | 2005 | 58 | 0.020 |
Why?
|